47 related articles for article (PubMed ID: 34624303)
1. Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus.
Sapoznikov B; Fisch G; Shamah S; Shinhar N; Benjaminov F; Levi Z; Peleg N
Dig Liver Dis; 2023 Dec; 55(12):1667-1672. PubMed ID: 37517963
[TBL] [Abstract][Full Text] [Related]
2. Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection and Ablation: A Large North American Multicenter Cohort.
Vantanasiri K; Joseph A; Sachdeva K; Goyal R; Garg N; Adoor D; Kamboj AK; Codipilly DC; Leggett C; Wang KK; Harmsen W; Hayat U; Chak A; Bhatt A; Iyer PG
Am J Gastroenterol; 2024 May; ():. PubMed ID: 38587280
[TBL] [Abstract][Full Text] [Related]
3. LIQUID NITROGEN SPRAY CRYOTHERAPY FOR ERADICATION OF DYSPLASTIC BARRETT'S ESOPHAGUS: RESULTS FROM A MULTICENTER PROSPECTIVE REGISTRY.
Eluri S; Cotton CC; Kaul V; McKinley M; Pleskow D; Nishioka N; Hoffman B; Nieto J; Tsai F; Coyle W; Kothari S; Joshi V; Dumot J; Greenwald B; Habr FG; Shaheen NJ
Gastrointest Endosc; 2024 Jan; ():. PubMed ID: 38272279
[TBL] [Abstract][Full Text] [Related]
4. Hybrid argon plasma coagulation for Barrett's esophagus.
Kolb JM; Shah S; Chahine A; Chang K; Samarasena JB
VideoGIE; 2021 Aug; 6(8):339-341. PubMed ID: 34401625
[TBL] [Abstract][Full Text] [Related]
5. Role of submucosal injection in radiofrequency ablation of gastric low-grade dysplasia: Effects on symptoms and outcomes.
Niu X; Wang N; Wang Y; Feng J; Li L; Han K; Chai N; Linghu E
Chin Med J (Engl); 2024 Apr; ():. PubMed ID: 38602084
[TBL] [Abstract][Full Text] [Related]
6. Administration of oral prednisolone to prevent esophageal stricture after balloon-type radiofrequency ablation for ultralong-segment esophageal neoplasia.
Wang WL; Tsai YN; Hsu MH; Lin JT; Wang HP; Lee CT
Gastrointest Endosc; 2024 Apr; ():. PubMed ID: 38583540
[TBL] [Abstract][Full Text] [Related]
7. Cryotherapy versus radiofrequency ablation in the treatment of dysplastic Barrett's esophagus with or without early esophageal neoplasia: a systematic review and meta-analysis.
Gomes ILC; de Moura DTH; Ribeiro IB; Marques SB; de Sousa Carlos A; Nunes BCM; Hirsch BS; de Oliveira GHP; Trasolini RP; Bernardo WM; de Moura EGH
Clin Endosc; 2024 Mar; 57(2):181-190. PubMed ID: 38229440
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic Management of Dysplastic Barrett's Oesophagus and Early Oesophageal Adenocarcinoma.
Eusebi LH; Telese A; Castellana C; Engin RM; Norton B; Papaefthymiou A; Zagari RM; Haidry R
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835470
[TBL] [Abstract][Full Text] [Related]
9. Improving clinical outcomes of Barrett's esophagus with high dose proton pump inhibitors and cryoablation.
Snady H
Ann Med; 2023 Dec; 55(1):1256-1264. PubMed ID: 37232568
[TBL] [Abstract][Full Text] [Related]
10. What Is "Cold" and What Is "Hot" in Mucosal Ablation for Barrett's Oesophagus-Related Dysplasia: A Practical Guide.
Spadaccini M; Alfarone L; Chandrasekar VT; Maselli R; Capogreco A; Franchellucci G; Massimi D; Fugazza A; Colombo M; Carrara S; Facciorusso A; Bhandari P; Sharma P; Hassan C; Repici A
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109552
[TBL] [Abstract][Full Text] [Related]
11. State-of-the-art management of dysplastic Barrett's esophagus.
Vantanasiri K; Iyer PG
Gastroenterol Rep (Oxf); 2022; 10():goac068. PubMed ID: 36381221
[TBL] [Abstract][Full Text] [Related]
12. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
Cotton CC; Eluri S; Shaheen NJ
Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
[TBL] [Abstract][Full Text] [Related]
13. Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study.
Agarwal S; Alshelleh M; Scott J; Dhaliwal L; Codipilly DC; Dierkhising R; Leggett CL; Wang KK; Otaki FA; Trindade AJ; Iyer PG
Gastrointest Endosc; 2022 Mar; 95(3):422-431.e2. PubMed ID: 34624303
[TBL] [Abstract][Full Text] [Related]
14. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
15. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of radiofrequency ablation failure in the treatment of dysplastic Barrett's esophagus.
Weiss S; Pellat A; Corre F; Abou Ali E; Belle A; Terris B; Leconte M; Dohan A; Chaussade S; Coriat R; Barret M
Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102065. PubMed ID: 36494071
[TBL] [Abstract][Full Text] [Related]
17. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett's esophagus: a critical assessment of histologic outcomes and adverse events.
Chadwick G; Groene O; Markar SR; Hoare J; Cromwell D; Hanna GB
Gastrointest Endosc; 2014 May; 79(5):718-731.e3. PubMed ID: 24462170
[TBL] [Abstract][Full Text] [Related]
18. Management of Barrett's esophagus with dysplasia refractory to radiofrequency ablation.
Raphael KL; Trindade AJ
World J Gastroenterol; 2020 May; 26(17):2030-2039. PubMed ID: 32536772
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
